Research on the Mechanism and Path of Digitalization Driving the Supply Chain Resilience of Pharmaceutical and Health Industry

Authors

  • Nanjun He, Guoqing Chen Author

DOI:

https://doi.org/10.71451/ISTAER2575

Abstract

Against the backdrop of frequent global public health emergencies and a complex, volatile international trade environment, the stability and security of the pharmaceutical and healthcare industry supply chain have become a critical component of national strategic security. This paper explores how digital technologies can enhance the resilience of the pharmaceutical and healthcare supply chain, systematically analyzing its underlying mechanisms and implementation pathways. The study concludes that digitalization significantly improves the supply chain's predictability, adaptability, and resilience through four key mechanisms: information transparency, intelligent processes, data-driven decision-making, and network collaboration. The proposed implementation pathways include: establishing a comprehensive data-sharing platform across the entire supply chain, deepening the application of artificial intelligence and Internet of Things (IoT) technologies, developing flexible supply chain network models, and establishing a robust digital governance framework. This research aims to provide theoretical references and practical guidance for relevant enterprises and policymakers.

References

[1]Cao Yi, Wang Kai, Ding Ning. The impact of supply chain digitalization on corporate resilience: A quasi-natural experiment based on supply chain innovation and application pilot policies [J]. Business Economics Research, 2025, (14):142-146.

[2]Guo Zhifang, Chen Yilan, Shen Xiaoxiang, et al. Digital Transformation and Corporate Export Resilience: A Study Based on Supply Chain Optimization [J]. Zhejiang Social Sciences, 2025, (11):26-38+157.=145

[3]Su Peng, Li Ziying. Facing 'Resilience' with Determination? A Study on the Impact of Supply Chain Digitalization on Corporate Performance[J]. Finance and Economics, 2025, (10):1-13.

[4]Han Xiaoyu, Deng Yu. Digitalization-driven upgrade of supply chain finance [J]. China Finance, 2020, (07):55-57.

[5]Luo Junmei, Hao Kangqi, Jiang Zhonghui. Research on the Formation Mechanism of Digital Restructuring Capability in Pharmaceutical Supply Chain from the Perspective of Institutional Entrepreneurship[J/OL]. Scientific Research Management, 1-15[2025-12-26]. https://link.cnki.netUrlid/11.1567.G3.20251218.1448.002.

[6]Zheng Xuemei, Zou Fenju. Research on the Path of Empowering Manufacturing Supply Chain Resilience with Digital Economy [J]. China Economic Issues, 2025, (05):79-94.

[7]Yuan Yehu, Wu Duanduan. Enterprise Digital Transformation and Supply Chain Resilience: A Perspective Based on Supply Chain Spillover [J]. Systems Engineering Theory and Practice, 2025,45(07):2309-2326.

Downloads

Published

2025-10-04

Issue

Section

Research Article

How to Cite

Research on the Mechanism and Path of Digitalization Driving the Supply Chain Resilience of Pharmaceutical and Health Industry. (2025). International Scientific Technical and Economic Research , 156-165. https://doi.org/10.71451/ISTAER2575